Bafna Pharmaceuticals
BAFNAPH •NSE

Bafna Pharmaceuticals

₹454.506.95 (1.55%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
454.40
Today’s high
456.50
52 week low
94.77
52 week high
479.95
Open price
456.50
Previous close
447.55
Live volume
10,171
Lower circuit
445.45
Upper circuit
463.55

Fundamentals

Market Cap
₹1,074Cr
ROE
11.54%
P/E Ratio(TTM)
138.02
EPS(TTM)
3.29
P/B Ratio
11.17
Dividend Yield
0.00%
Industry P/E
50.89
Book Value
40.64
Debt to Equity
0.39
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
JUN '26
₹28.49Cr
-35.25%
₹0.08Cr
-97.09%
015304560
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Revenue growthValue
1Y (TTM)-19%
3Y CAGR+9%
Profit growthValue
1Y (TTM)-98%
3Y CAGR-1%

About

Bafna Pharmaceuticals Limited manufactures pharmaceutical formulations, including betalactum and non-betalactum products, for domestic and export markets.;
CEO/MD
Bafna Mahaveer Chand
Founded in
1995
NSE symbol
BAFNAPH
Industry

Shareholding pattern

Sep '25
Dec '25
Mar '26
Jun '26
Sep '26
Shareholder details

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹2,382.50
-38.90 (1.61%)
L
    H
    18,414.2127.165.46
    PfizerPFIZER
    ₹3,856.00
    -0.90 (0.02%)
    L
      H
      17,641.2420.534.2
      ₹6,373.50
      +79.50 (1.26%)
      L
        H
        15,737.2592.7818.03
        Natco PharmaNATCOPHARM
        ₹807.00
        +10.40 (1.31%)
        L
          H
          15,623.8013.651.49
          2026
          11
          Aug
          Quarterly Result
          Release date
          29
          May
          Annual Result
          Release date
          11
          Feb
          Quarterly Result
          Release date
          2025
          11
          Nov
          Quarterly Result
          Release date
          12
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks